来自瘤流体的ANGPTL2增强了免疫检查点抑制剂的有效性
Haruki Horiguchi1,2, Tsuyoshi Kadomatsu3,4, Tomoya Yamashita3
1Department of Molecular Genetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, 860-8556, Japan. horiguti@kumamoto-u.ac.jp.
Cancer gene therapy
|March 12, 2024
概括
血管类蛋白2 (ANGPTL2) 通过促进T细胞反应来增强抗瘤免疫力. 这一发现表明,ANGPTL2可以提高免疫检查点抑制剂 (ICI) 在癌症治疗中的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 免疫检查点抑制剂 (ICI) 是现代癌症免疫治疗的基石.
- 来自瘤肌瘤的angiopoietin-like protein 2 (ANGPTL2) 之前通过增强树突细胞介导的CD8+ T细胞反应,已经显示出瘤抑制活性.
- ANGPTL2在调节ICI疗效方面的直接作用在很大程度上仍未被探索.
研究的目的:
- 研究ANGPTL2对免疫检查点抑制剂抗瘤作用的直接影响.
- 在ICI治疗的背景下,阐明 ANGPTL2 影响 T 细胞介导的抗瘤免疫的机制.
主要方法:
- 利用一种小鼠合成基因模型来评估宿主ANGPTL2在抗瘤免疫反应中的作用.
- 分析了用ICI治疗的人类黑色素瘤患者的公共数据集,以将ANGPTL2表达与治疗结果相关联.
主要成果:
- 发现宿主ANGPTL2有助于CD8+T细胞的交叉化,这是启动抗瘤免疫反应的关键步骤.
- 在实验模型中,宿主组织中的ANGPTL2表达与ICI增强的抗瘤作用直接相关.
- 对人类黑色素瘤患者数据的分析显示,较高的ANGPTL2表达和对ICI治疗的积极反应之间存在显著的关联.
结论:
- ANGPTL2通过增强T细胞激活和对ICI的反应,在促进抗瘤免疫力方面发挥着至关重要的作用.
- 肌体细胞和免疫细胞之间的ANGPTL2介导的交叉声是ICI疗效的关键调节者.
- 这些发现突出了ANGPTL2作为一种潜在的生物标志物和治疗点,用于改善癌症治疗中的ICI响应能力.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
738
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K